Dr. Miriam Cortes Cerisuelo is a consultant surgeon in adult and paediatric liver transplantation in King’s College Hospital since April 2016. In 2002, she graduated from Barcelona University, and completed a general surgery residency in my Centre, which as you all know, is the largest liver transplant programme in Spain. After she was awarded with a post-residency research grant in 2009, she completed her doctorate in metabolomics, a useful tool to predict liver functionality after liver transplant in the University of Valencia. In 2012, she was appointed as a clinical liver transplant fellow in King’s College Hospital which is the largest liver transplant service in Europe (260 liver transplants last year, of which 50 were paediatrics) and performs all types of procedures such as split liver transplantation, donation after circulatory dead, living donation, auxiliary liver transplant, ex-vivo normothermic and hypothermic perfusion. In 2015 she was awarded by the Medical Research Council in England, an MRC Centre for Transplantation/Emory Bridging Fellowship which funded her with one-year post-doctoral fellowship in one of the leading Immunology Transplant Centres in the United States where she worked under the direction of Dr Mandy Ford, scientific director in “Emory Transplant Centre”. Her research focused in finding biomarkers to predict belatacept resistant rejection in patients undergoing kidney transplantation. In 2019, she was appointed as lead for organ retrieval and machine perfusion at King’s College Hospital, since then, she has incorporated the ex-situ hypothermic machine perfusion initially as part of her contribution to HOPE and DHOPE trials and more recently as part of the clinical practice. As a consultant she has been involved in numerous committees and working groups mainly in UK such as the NRP steering group to develop a national standard operating procedure, national working group to update the DCD liver transplant guidelines, working group for liver machine perfusion; an internationally in the DCD consensus conference lead by the ILTS. Her main clinical interests are focused on paediatric liver transplantation and patterns of portal hypertension in young adults requiring a liver transplant, as well as machine perfusion and DCD liver transplantation. Other research interests are the impact of machine perfusion on alloimmune responses and developing more accurate scoring systems of early allograft function after transplantation.